Johnson & Johnson vaccine temporarily removed for safety concerns

Rare blood clots found as symptoms after 7 million already receive vaccine

https%3A%2F%2Fwww.google.com%2Furl%3Fsa%3Di%26url%3Dhttps%253A%252F%252Ftime.com%252F5929675%252Fjohnson-johnsons-1-shot-covid-19-vaccine-shows-promise-in-early-stage-trials%252F%26psig%3DAOvVaw2e2no8iJ8DxqmI9nERfV1I%26ust%3D1619006820705000%26source%3Dimages%26cd%3Dvfe%26ved%3D0CAIQjRxqFwoTCICF3OHkjPACFQAAAAAdAAAAABAP%0A

https://www.google.com/url?sa=i&url=https%3A%2F%2Ftime.com%2F5929675%2Fjohnson-johnsons-1-shot-covid-19-vaccine-shows-promise-in-early-stage-trials%2F&psig=AOvVaw2e2no8iJ8DxqmI9nERfV1I&ust=1619006820705000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCICF3OHkjPACFQAAAAAdAAAAABAP

Nadia Villegas, Copy Editor

As of April 12, according to the CDC, more than 6.8 million Johnson & Johnson immunizations have been dispersed in the U.S.

CDC and FDA are checking on information including six detailed U.S. instances of an uncommon and extreme kind of blood clotting in people subsequent to getting the J&J immunization.

In these cases, a kind of blood clump called cerebral venous sinus apoplexy (CVST) was found in mix with low degrees of blood platelets (thrombocytopenia).

Every one of the six cases happened among women between the ages of 18 and 48, and indications happened 6 to 13 days after immunization. Treatment of this particular sort of blood clump is unique in relation to the treatment that is typically delivered.

Normally, an anticoagulant drug called heparin is utilized to treat blood clumps. In this setting, organization of heparin might be dangerous, and alternative medicines should be considered.

In even more recent news, newer Johnson & Johnson vaccines have been delayed after a factory incident. Laborers at a plant in Baltimore manufacturing two COVID-19 immunizations accidentally combined the ingredients a little while back, tainting up to 15 million portions of Johnson & Johnson’s vaccine and forcing a delay on production lines. None of these doses left the plant.

This contamination poses a lot of concerns for many and in a recent interview many addressed their own opinions on the vaccines.

Junior and part time worker Riley Happel recently stated “The Johnson & Johnson vaccine is definitely a priority for me, I want to get it as soon as possible. But, I’m not sure on how I feel about Johnson & Johnson right now.”

It’s clear many have concerns about the Johnson & Johnson vaccine, but many seem to have little concern as for the other vaccines, trusting in the CDC’s positive regards for them.

Junior Katie Hlavinka said that she’s had her first dose of the Pfizer vaccine but if she had a choice to get the Johnson & Johnson vaccine she stated, “probably not, it had complications once who’s to say it won’t happen again?”